Pharmacological enhancement of motor recovery in subacute and chronic stroke

NeuroRehabilitation

Volumn 23, Issue 1, 2008, Pages 95-103

  Rösser, Nina ^b   Flöel, Agnes ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acetylcholine; Amphetamine; Brain damage; Dopamine; G CSF; Motor rehabilitation; Serotonin

Indexed keywords

AMPHETAMINE; ANTICONVULSIVE AGENT; ATOMOXETINE; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CABERGOLINE; CARBIDOPA; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DEXAMPHETAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DONEPEZIL; FLUOXETINE; GRANULOCYTE COLONY STIMULATING FACTOR; HALOPERIDOL; IDAZOXAN; LEVODOPA; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PHENOXYBENZAMINE; PLACEBO; PRAZOSIN; REBOXETINE; SCOPOLAMINE; SEROTONIN; TACRINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; YOHIMBINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CENTRAL NERVOUS SYSTEM AGENTS;

ANOREXIA; BLOOD PRESSURE; CLINICAL STUDY; CLINICAL TRIAL; CONVALESCENCE; DIARRHEA; DRUG DOSE TITRATION; DRUG EFFECT; EXPERIMENTAL STUDY; HEART ARRHYTHMIA; HUMAN; INTERVENTION STUDY; MOTOR SYSTEM; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; PHYSIOTHERAPY; REHABILITATION CARE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STROKE; VOMITING; WEIGHT REDUCTION; ANIMAL; MOTOR ACTIVITY;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; RECOVERY OF FUNCTION; STROKE;

EID: 44449111333     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2008-23110     Document Type: Review

References (73)

1. S. Bao, C.V. and M.M. Merzenich, Cortical remodelling induced by activity of ventral tegmental dopamine neurons, Nature 412 (2001), 79-83.
2. P.M. Bath and N. Sprigg, Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke, Cochrane Database Syst Rev 3 (2006), CD005207.
3. K. Blennow, M.J. de Leon and H. Zetterberg, Alzheimer's disease, Lancet 368 (2006), 387-403.
4. M.G. Boyeson, T.R. Callister and J.E. Cavazos, Biochemical and Behavioral-Effects of A Sensorimotor Cortex Injury in Rats Pretreated with the Noradrenergic Neurotoxin Dsp-4, Behavioral Neuroscience 106 (1992), 964-973.
5. M.G. Boyeson and D.M. Feeney, Intraventricular Norepinephrine Facilitates Motor Recovery Following Sensorimotor Cortex Injury, Pharmacology Biochemistry and Behavior 35 (1990), 497-501.
6. M.G. Boyeson and D.M. Feeney, Adverse-Effects of Catecholaminergic Drugs Following Unilateral Cerebellar Ablations, Restorative Neurology and Neuroscience 3 (1991), 227-233.
7. C.M. Butefisch, B.C. Davis, L. Sawaki, D. Waldvogel, J. Classen, L. Kopylev and L.G. Cohen, Modulation of use-dependent plasticity by d-amphetamine, Ann Neurol 51 (2002), 59-68.
8. D. Centonze, B. Picconi, P. Gubellini, G. Bernardi and P. Calabresi, Dopaminergic control of synaptic plasticity in the dorsal striatum, Eur J Neurosci 13 (2001), 1071-1077.
9. J.M. Conner, A. Culberson, C. Packowski, A.A. Chiba and M.H. Tuszynski, Lesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning, Neuron 38 (2003), 819-829.
10. A.L. Coppell, Q. Pei and T.S.C. Zetterstrom, Bi-phasic change in BDNF gene expression following antidepressant drug treatment, Neuropharmacology 44 (2003), 903-910.
11. J.V. Corwin, S. Kanter, R.T.Watson, K.M. Heilman, E. Valenstein and A. Hashimoto, Apomorphine has a therapeutic effect on neglect produced by unilateral dorsomedial prefrontal cortex lesions in rats, Exp Neurol 94 (1986), 683-698.
12. E.A. Crisostomo, P.W. Duncan, M. Propst, D.V. Dawson and J.N. Davis, Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients, Ann Neurol 23 (1988), 94-97.
13. M. Dam, P. Tonin, A. DeBoni, G. Pizzolato, S. Casson, M. Ermani, U. Freo, L. Piron and L. Battistin, Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy, Stroke 27 (1996), 1211-1214.
14. W.D. Dietrich, O. Alonso, R. Busto, B.D. Watson, Y. Loor and M.D. Ginsberg, Influence of Amphetamine Treatment on Somatosensory Function of the Normal and Infarcted Rat-Brain, Stroke 21 (1990), 147-150.
15. B.H. Dobkin, Neurobiology of rehabilitation, Ann N Y Acad Sci 1038 (2004), 148-170.
16. D.M. Feeney, A. Gonzalez and W.A. Law, Amphetamine, Haloperidol, and Experience Interact to Affect Rate of Recovery After Motor Cortex Injury, Science 217 (1982), 855-857.
17. D.M. Feeney and D.A. Hovda, Amphetamine and Apomorphine Restore Tactile Placing After Motor Cortex Injury in the Cat, Psychopharmacology 79 (1983), 67-71.
18. D.M. Feeney and D.A. Hovda, Reinstatement of Binocular Depth-Perception by Amphetamine and Visual Experience After Visual-Cortex Ablation, Brain Research 342 (1985), 352-356.
19. A. Floel, C. Breitenstein, F. Hummel, P. Celnik, C. Gingert, L. Sawaki, S. Knecht and L.G. Cohen, Dopaminergic influences on formation of a motor memory, Ann Neurol 58 (2005), 121-130.
20. A. Floel, G. Garraux, B. Xu, C. Breitenstein, S. Knecht, P. Herscovitch and L.G. Cohen, Levodopa increases memory encoding and dopamine release in the striatum in the elderly, Neurobiol Aging (2006).
21. A. Floel, F. Hummel, C. Breitenstein, S. Knecht and L.G. Cohen, Dopaminergic effects on encoding of a motor memory in chronic stroke, Neurology 65 (2005), 472-474.
22. D.J. Foster, D.C. Good, A. Fowlkes and L. Sawaki, Atomoxetine enhances a short-term model of plasticity in humans, Archives of Physical Medicine and Rehabilitation 87 (2006), 216-221.
23. A.R. Fugl-Meyer, L. Jaasko, I. Leyman, S. Olsson and S. Steglind, The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance, Scand J Rehabil Med 7 (1975), 13-31.
24. D.J. Gladstone, C.J. Danells, A. Armesto, W.E. McIlroy, W.R. Staines, S.J. Graham, N. Herrmann, J.P. Szalai and S.E. Black, Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial, Stroke 37 (2006), 179-185.
25. L.B. Goldstein, Influence of common drugs and related factors on stroke outcome, Current Opinion in Neurology 10 (1997), 52-57.
26. L.B. Goldstein, A. Covielo, G.D. Miller and J.N. Davis, Norepinephrine Depletion Impairs Motor Recovery Following Sensorimotor Cortex Injury in the Rat, Restorative Neurology and Neuroscience 3 (1991), 41-47.
27. L.B. Goldstein, H.V. Poe and J.N. Davis, An Animal-Model of Recovery of Function After Stroke - Facilitation of Recovery by An Alpha-2-Adrenergic Receptor Antagonist, Annals of Neurology 26 (1989), 157.
28. R. Grondin, Z. Zhang, G.A. Gerhardt and D.M. Gash, Dopaminergic therapy improves upper limb motor performance in aged rhesus monkeys, Ann Neurol 48 (2000), 250-253.
29. M.E. Hasselmo and E. Barkai, Cholinergic modulation of activity-dependent synaptic plasticity in the piriform cortex and associative memory function in a network biophysical simulation, J Neurosci 15 (1995), 6592-6604.
30. H.T. Hendricks, J. van Limbeek, A.C. Geurts and M.J. Zwarts, Motor recovery after stroke: A systematic review of the literature, Archives of Physical Medicine and Rehabilitation 83 (2002), 1629-1637.
31. D.A. Hovda and D.M. Fenney, Amphetamine with Experience Promotes Recovery of Locomotor Function After Unilateral Frontal-Cortex Injury in the Cat, Brain Research 298 (1984), 358-361.
32. B.E. Hurwitz, W.D. Dietrich, P.M. Mccabe, O. Alonso, B.D. Watson, M.D. Ginsberg and N. Schneiderman, Amphetamine Promotes Recovery from Sensory Motor Integration Deficit After Thrombotic Infarction of the Primary Somatosensory Rat Cortex, Stroke 22 (1991), 648-654.
33. B.L. Jacobs and C.A. Fornal, 5-HT and motor control: a hypothesis, Trends Neurosci 16 (1993), 346-352.
34. T.M. Jay, Dopamine: a potential substrate for synaptic plasticity and memory mechanisms, Prog Neurobiol 69 (2003), 375-390.
35. S.J. Kish, L.M. Distefano, S. Dozic, Y. Robitaille, A. Rajput, J.H. Deck and O. Hornykiewicz, [3H]vesamicol binding in human brain cholinergic deficiency disorders, Neurosci Lett 117 (1990), 347-352.
36. D. Long and J. Young, Dexamphetamine treatment in stroke, QJM 96 (2003), 673-685.
37. I. Loubinoux, J. Pariente, K. Boulanouar, C. Carel, C. Manelfe, O. Rascol, P. Celsis and F. Chollet, A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: Double-blind, placebo-controlled, fMRI study in healthy subjects, Neuroimage 15 (2002), 26-36.
38. I. Loubinoux, J. Pariente, O. Rascol, P. Celsis and F. Chollet, Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects, Neuropsychologia 40 (2002), 1815-1821.
39. I. Loubinoux, D. Tombari, J. Pariente, A. Gerdelat-Mas, X. Franceries, E. Cassol, O. Rascol, J. Pastor and F. Chollet, Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer, Neuroimage 27 (2005), 299-313.
40. M. Maalouf, A.A. Miasnikov and R.W. Dykes, Blockade of cholinergic receptors in rat barrel cortex prevents long-term changes in the evoked potential during sensory preconditioning, J Neurophysiol 80 (1998), 529-545.
41. M.B. Macht, Effects of Delta-Amphetamine on Hemi-Decorticate, Decorticate, and Decerebrate Cats, American Journal of Physiology 163 (1950), 731-732.
42. L. Martinsson and S. Eksborg, Drugs for stroke recovery - The example of amphetamines, Drugs & Aging 21 (2004), 67-79.
43. L. Martinsson and N.G.Wahlgren, Safety of dexamphetamine in acute ischemic stroke - A randomized, double-blind, controlled dose-escalation trial, Stroke 34 (2003), 475-481.
44. L. Martinsson, N.G. Wahlgren and H.G. Hardemark, Amphetamines for improving recovery after stroke, Cochrane Database Syst Rev (2003), CD002090.
45. F. Meintzschel and U. Ziemann, Modification of practice-dependent plasticity in human motor cortex by neuromodulators, Cereb Cortex 16 (2006), 1106-1115.
46. M. Mintz and R. Tomer, Exposure to amphetamine after substantia nigra lesion interferes with the process of behavioral recovery, Pharmacol Biochem Behav 25 (1986), 1307-1311.
47. J. Pariente, I. Loubinoux, C. Carel, J.F. Albucher, A. Leger, C. Manelfe, O. Rascol and F. Chollet, Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke, Ann Neurol 50 (2001), 718-729.
48. J.P. Phillips, D.J. Devier and D.M. Feeney, Rehabilitation pharmacology: bridging laboratory work to clinical application, J Head Trauma Rehabil 18 (2003), 342-356.
49. C. Plewnia, J. Hoppe, L.G. Cohen and C. Gerloff, Improved motor skill acquisition after selective stimulation of central norepinephrine, Neurology 62 (2004), 2124-2126.
50. C. Plewnia, J. Hoppe and C. Gerloff, No effects of enhanced central norepinephrine on finger-sequence learning and attention, Psychopharmacology 187 (2006), 260-265.
51. P.M. Rossini, C. Calautti, F. Pauri and J.C. Baron, Post-stroke plastic reorganisation in the adult brain, Lancet Neurol 2 (2003), 493-502.
52. M. Sarter and J.P. Bruno, Cognitive functions of cortical acetylcholine: toward a unifying hypothesis, Brain Res Brain Res Rev 23 (1997), 28-46.
53. M. Sarter and J.P. Bruno, Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers, Behav Brain Res 83 (1997), 7-14.
54. L. Sawaki, B. Boroojerdi, A. Kaelin-Lang, A.H. Burstein, C.M. Butefisch, L.Kopylev, B. Davis and L.G. Cohen, Cholinergic influences on use-dependent plasticity, J Neurophysiol 87 (2002), 166-171.
55. L. Sawaki, L.G. Cohen, J. Classen, B.C. Davis and C.M. Butefisch, Enhancement of use-dependent plasticity by D-amphetamine, Neurology 59 (2002), 1262-1264.
56. W.R. Schabitz and A. Schneider, Developing granulocyte-colony stimulating factor for the treatment of stroke: Current status of clinical trials, Stroke 37 (2006), 1654.
57. K. Scheidtmann, Advances in adjuvant pharmacotherapy for motor rehabilitation: effects of levodopa, Restor Neurol Neurosci 22 (2004), 393-398.
58. K. Scheidtmann, W. Fries, F. Muller and E. Koenig, Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study, Lancet 358 (2001), 787-790.
59. T. Schmanke and T.M. Barth, Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat, J Neurotrauma 14 (1997), 459-468.
60. T.D. Schmanke, R.A. Avery and T.M. Barth, The effects of amphetamine on recovery of function after cortical damage in the rat depend on the behavioral requirements of the task, J Neurotrauma 13 (1996), 293-307.
61. W. Schultz, Multiple reward signals in the brain, Nat Rev Neurosci 1 (2000), 199-207.
62. L. Sonde and J. Lokk, Effects of amphetamine and/or l-dopa and physiotherapy after stroke - a blinded randomized study, Acta Neurol Scand 115 (2007), 55-59.
63. L. Sonde, M. Nordstrom, C.G. Nilsson, J. Lokk and M. Viitanen, A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke, Cerebrovasc Dis 12 (2001), 253-257.
64. R.P. Stroemer, T.A.Kent and C.E. Hulsebosch, Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats, Stroke 29 (1998), 2381-2393.
65. R.L. Sutton and D.M. Feeney, Alpha-Noradrenergic Agonists and Antagonists Affect Recovery and Maintenance of Beam-Walking Ability After Sensorimotor Cortex Ablation in the Rat, Restorative Neurology and Neuroscience 4 (1992), 1-11.
66. R.L. Sutton, D.A. Hovda and D.M. Feeney, Amphetamine Accelerates Recovery of Locomotor Function Following Bilateral Frontal-Cortex Ablation in Cats, Behavioral Neuroscience 103 (1989), 837-841.
67. E. Taub, G. Uswatte and T. Elbert, New treatments in neurorehabilitation founded on basic research, Nature Reviews Neuroscience 3 (2002), 228-236.
68. T. Treig, C. Werner, M. Sachse and S. Hesse, No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study, Clinical Rehabilitation 17 (2003), 590-599.
69. E. Troisi, S. Paolucci, M. Silvestrini, M. Matteis, F. Vernieri, M.G. Grasso and C. Caltagirone, Prognostic factors in stroke rehabilitation: the possible role of pharmacological treatment, Acta Neurologica Scandinavica 105 (2002), 100-106.
70. E.A.Van der Zee and P.G.M. Luiten, Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: A review of immunocytochemical localization in relation to learning and memory, Progress in Neurobiology 58 (1999), 409-471.
71. D. Walker-Batson, P. Smith, S. Curtis, H. Unwin and R. Greenlee, Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence, Stroke 26 (1995), 2254-2259.
72. V. Windle and D. Corbett, Fluoxetine and recovery of motor function after focal ischemia in rats, Brain Research 1044 (2005), 25-32.
73. R.D. Zorowitz, Road to recovery: drugs used in stroke rehabilitation, Expert Rev Neurother 4 (2004), 219-231.